Company
Lyell Immunopharma
Lyell Immunopharma has 5 drugs tracked on RxWires: 1 in Phase 3, 2 in Phase 1/2, 2 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| rondecabtagene autoleucel | Phase 3 | Large B-cell Lymphoma |
| LYL273 | Phase 1/2 | Colorectal Cancer |
| IMPT-514 | Phase 1/2 | Systemic Lupus Erythematosus |
| LYL845 | Phase 1 | Melanoma |
| LYL797 | Phase 1 | Triple Negative Breast Cancer |
Latest
- lyell immunopharma filed 8-K
- lyell immunopharma filed 8-K
- lyell immunopharma filed 8-K
- lyell immunopharma filed 8-K
- lyell immunopharma filed 8-K
Follow Lyell Immunopharma on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.